• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

MIFEPRISTONE Drug Record

  • Summary
  • Interactions
  • Claims
  • MIFEPRISTONE chembl:CHEMBL1276308 Approved

    Alternate Names:

    MIFEPRISTONE
    MIFEPREX
    RU-38486
    KORLYM
    MIFEGYNE
    RU486
    RU-486
    11-(4-DIMETHYLAMINO-PHENYL)-17-HYDROXY-13-METHYL-17-PROP-1-YNYL-1,2,6,7,8,11,12,13,14,15,16,17-DODEC AHYDRO-CYCLOPENTA[A]PHENANTHREN-3-ONE
    MIFEPREX®
    MIFEPRISTONUM
    MIFEPRISTON
    CORLUX
    MIFÉPRISTONE
    MIFEPRISTONA
    chembl:CHEMBL1276308
    rxcui:6964
    pubchem.compound:55245
    chemidplus:84371-65-3
    drugbank:00834

    Drug Info:

    Year of Approval 2000
    Drug Class abortifacient agents
    Drug Indications antipsychotic,antidepressant
    FDA Approval approved
    Drug Class Small Molecule
    Drug Indications opthalmological agent,for lowering intraocular pressure
    (5 More Sources)

    Publications:

    Galand, 1988, Effect of an antiglucocorticoid (RU-38486) on hydrocortisone induction of maltase-glucosamylase, sucrase-isomaltase and trehalase in brush border membranes of suckling rats., Experientia
    Zarghami et al., 1997, Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer., Br. J. Cancer
    Kang Z et al., 2004, Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor., Mol Endocrinol
    Sun et al., 1998, [Effect of mifepristone on the expression of progesterone receptor messenger RNA and protein in uterine leiomyomata]., Zhonghua Fu Chan Ke Za Zhi
    Hazra et al., 2000, Synthesis of 11beta-(4-dimethylaminophenyl)-17beta-hydroxy-17alpha- (3-methyl-1-butynyl)-4, 9-estradien-3-one and 11beta-(4-acetophenyl)- 17beta-hydroxy-17alpha-(3-methyl-1-butynyl)-4, 9-estradien-3-one: two new analogs of mifepristone (RU-486)., Steroids
    Jiang et al., 2001, [Effects of mifepristone on expression of estrogen receptor and progesterone receptor in cultured human eutopic and ectopic endometria]., Zhonghua Fu Chan Ke Za Zhi
    Greb et al., 1999, Disparate actions of mifepristone (RU 486) on glands and stroma in the primate endometrium., Hum. Reprod.
    Chen et al., 2002, TTD: Therapeutic Target Database., Nucleic Acids Res.
    Gao et al., 1998, [Failure of mifepristone induced interruption of pregnancy: point mutation at genetic codon 722 in human progesterone receptor gene]., Zhonghua Fu Chan Ke Za Zhi
    Liu et al., 1999, Mifepristone regulation of leukemia inhibitory factor and uterine receptivity in rabbits., Contraception
    LeVan et al., 1999, Pharmacological characterization of glucocorticoid receptors in primary human bronchial epithelial cells., Biochem. Pharmacol.
    Gu et al., 2005, Estrogen protects primary osteocytes against glucocorticoid-induced apoptosis., Apoptosis
    de Pablos et al., 2006, Stress increases vulnerability to inflammation in the rat prefrontal cortex., J. Neurosci.
    Aida et al., 2004, The effects of betamethasone (BM) on endothelial nitric oxide synthase (eNOS) expression in adult baboon femoral arterial endothelial cells., J. Steroid Biochem. Mol. Biol.
    Attardi et al., 2004, In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone., J. Steroid Biochem. Mol. Biol.
    Mackin et al., 2007, Changes in brain-derived neurotrophic factor following treatment with mifepristone in bipolar disorder and schizophrenia., Aust N Z J Psychiatry
    Rendic S et al., 1997, Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors., Drug Metab Rev
  • MIFEPRISTONE   SI

    Interaction Score: 1.3

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    3132399


    Sources:
    NCI

  • MIFEPRISTONE   LIF

    Interaction Score: 0.59

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    10717784


    Sources:
    NCI

  • MIFEPRISTONE   PGR

    Interaction Score: 0.57

    Interaction Types & Directionality:
    agonist (activating)
    antagonist (inhibitory)

    Interaction Info:
    Mechanism of Interaction Progesterone receptor antagonist
    Direct Interaction yes
    Trial Name Mifepristone, RU486

    PMIDs:
    10682471 10699595 11783365 10374120 11752352 10806733


    Sources:
    TdgClinicalTrial ChemblInteractions TEND

  • MIFEPRISTONE   KLK3

    Interaction Score: 0.54

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    9052414 15308689


    Sources:
    NCI

  • MIFEPRISTONE   NR3C1

    Interaction Score: 0.23

    Interaction Types & Directionality:
    antagonist (inhibitory)

    Interaction Info:
    Trial Name Mifepristone, RU486
    Novel drug target Established target
    Trial Name mifepristone,Corlux

    PMIDs:
    10796070 15909120 16723527 15336699 15120421


    Sources:
    DTC TdgClinicalTrial ChemblInteractions TTD

  • MIFEPRISTONE   BDNF

    Interaction Score: 0.1

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17464718


    Sources:
    NCI

  • MIFEPRISTONE   GNAS

    Interaction Score: 0.09

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • MIFEPRISTONE   NPSR1

    Interaction Score: 0.04

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • MIFEPRISTONE   MPHOSPH8

    Interaction Score: 0.03

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • MIFEPRISTONE   MTOR

    Interaction Score: 0.03

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • MIFEPRISTONE   DRD1

    Interaction Score: 0.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • MIFEPRISTONE   CBX1

    Interaction Score: 0.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • MIFEPRISTONE   ABCB1

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    PharmGKB

  • MIFEPRISTONE   BAZ2B

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • MIFEPRISTONE   KDM4A

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • MIFEPRISTONE   CYP3A4

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    9187528


    Sources:
    PharmGKB

  • MIFEPRISTONE   NFE2L2

    Interaction Score: 0.0

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • MIFEPRISTONE   AR

    Interaction Score: 0.0

    Interaction Types & Directionality:
    antagonist (inhibitory)

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • MIFEPRISTONE   EHMT2

    Interaction Score: 0.0

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC

  • TEND: MIFEPRISTONE

    • Version: 01-August-2011

    Alternate Names:
    MIFEPRISTONE Primary Drug Name

    Drug Info:
    Drug Class abortifacient agents
    Year of Approval 2000

    Publications:

  • TdgClinicalTrial: MIFEPRISTONE

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications opthalmological agent,for lowering intraocular pressure
    Drug Class Small Molecule
    FDA Approval approved

    Publications:

  • NCI: MIFEPRISTONE

    • Version: 14-September-2017

    Alternate Names:
    C655 NCI drug code

    Drug Info:

    Publications:
    Zarghami et al., 1997, Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer., Br. J. Cancer
    Mackin et al., 2007, Changes in brain-derived neurotrophic factor following treatment with mifepristone in bipolar disorder and schizophrenia., Aust N Z J Psychiatry
    Liu et al., 1999, Mifepristone regulation of leukemia inhibitory factor and uterine receptivity in rabbits., Contraception

  • NCI: RU-38486

    • Version: 14-September-2017

    Alternate Names:
    C655 NCI drug code

    Drug Info:

    Publications:
    Galand, 1988, Effect of an antiglucocorticoid (RU-38486) on hydrocortisone induction of maltase-glucosamylase, sucrase-isomaltase and trehalase in brush border membranes of suckling rats., Experientia

  • PharmGKB: mifepristone

    • Version: 18-August-2020

    Alternate Names:

    Drug Info:

    Publications:
    Rendic S et al., 1997, Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors., Drug Metab Rev

  • DTC: MIFEPRISTONE

    • Version: 02-September-2020

    Alternate Names:
    CHEMBL1276308 ChEMBL Drug ID

    Drug Info:

    Publications:

  • TTD: Mifepristone

    • Version: 2020.06.01

    Alternate Names:
    D0Z4EI TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL1276308

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

  • ChemblInteractions: CHEMBL1276308

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21